Paper40316617
Impact of CYP2D6, MAOA, and UGT2B7 genetic variants on recurrence of Plasmodium Vivax in the Brazilian Amazon.
da Silva GS and 11 others. Sci Rep, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Impact of CYP2D6, MAOA, and UGT2B7 genetic variants on recurrence of Plasmodium Vivax in the Brazilian Amazon. Papers, record 40316617. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40316617
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of CYP2D6, MAOA, and UGT2B7 genetic variants on recurrence of Plasmodium Vivax in the Brazilian Amazon.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytochrome P-450 CYP2D6 | Major topic |
| Malaria, Vivax | Major topic |
| Plasmodium vivax | Major topic |
| Glucuronosyltransferase | Major topic |
| Monoamine Oxidase | Major topic |
| Humans | |
| Brazil | |
| Male | |
| Female | |
| Adult | |
| Case-Control Studies | |
| Recurrence | |
| Primaquine | |
| Genotype | |
| Young Adult | |
| Middle Aged | |
| Alleles | |
| Antimalarials | |
| Adolescent | |
| Polymorphism, Single Nucleotide | |
| Gene Frequency |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30379233 | Levels of primaquine and carboxyprimaquine in patients with malaria vivax from the Brazilian Amazon basin. | Rev Inst Med Trop Sao Paulo | 2018 | https://conductscience.org/library/papers/30379233 | PubMed |
| 2 | 30706164 | Effects of MAO-A and CYP450 on primaquine metabolism in healthy volunteers. | Parasitol Res | 2019 | https://conductscience.org/library/papers/30706164 | PubMed |
| 3 | 29390987 | CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study. | Malar J | 2018 | https://conductscience.org/library/papers/29390987 | PubMed |
| 4 | 33529838 | Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters. | Int J Parasitol Drugs Drug Resist | 2021 | https://conductscience.org/library/papers/33529838 | PubMed |
| 5 | 23782898 | The metabolism of primaquine to its active metabolite is dependent on CYP 2D6. | Malar J | 2013 | https://conductscience.org/library/papers/23782898 | PubMed |
| 6 | 25329392 | Distribution of CYP2D6 alleles and phenotypes in the Brazilian population. | PLoS One | 2014 | https://conductscience.org/library/papers/25329392 | PubMed |
| 7 | 32021383 | Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine. | Pharmgenomics Pers Med | 2020 | https://conductscience.org/library/papers/32021383 | PubMed |
| 8 | 22856549 | CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine. | Malar J | 2012 | https://conductscience.org/library/papers/22856549 | PubMed |
| 9 | 27093859 | Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes. | Malar J | 2016 | https://conductscience.org/library/papers/27093859 | PubMed |
| 10 | 12815363 | Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. | Pharmacogenomics J | 2003 | https://conductscience.org/library/papers/12815363 | PubMed |
| 11 | 24088113 | Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. | N Engl J Med | 2013 | https://conductscience.org/library/papers/24088113 | PubMed |
| 12 | 32122891 | Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32122891 | PubMed |
| 13 | 19214141 | Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression. | Pharmacogenet Genomics | 2009 | https://conductscience.org/library/papers/19214141 | PubMed |
| 14 | 34474178 | Plasmodium vivax pre-erythrocytic stages and the latent hypnozoite. | Parasitol Int | 2021 | https://conductscience.org/library/papers/34474178 | PubMed |
| 15 | 35452835 | Effects of CYP2D6 genotypes on Plasmodium vivax recurrence after primaquine treatment: A meta-analysis. | Travel Med Infect Dis | 2022 | https://conductscience.org/library/papers/35452835 | PubMed |
| 16 | 27030414 | Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria. | Proc Biol Sci | 2016 | https://conductscience.org/library/papers/27030414 | PubMed |
| 17 | 38667528 | Aggressiveness in Italian Children with ADHD: MAOA Gene Polymorphism Involvement. | Diseases | 2024 | https://conductscience.org/library/papers/38667528 | PubMed |
| 18 | 30103751 | Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry. | Malar J | 2018 | https://conductscience.org/library/papers/30103751 | PubMed |
| 19 | 16409140 | Pharmacogenomics and individualized drug therapy. | Annu Rev Med | 2006 | https://conductscience.org/library/papers/16409140 | PubMed |
| 20 | 27388693 | Prediction of CYP2D6 phenotype from genotype across world populations. | Genet Med | 2017 | https://conductscience.org/library/papers/27388693 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42888416 | CYP3A and CYP2D6 variability in antimalarial pharmacokinetics and pharmacogenetics across populations: a narrative review. | Malar J | 2026 | https://conductscience.org/library/papers/42888416 | PubMed |
| 42484259 | The Landscape of Malaria in a Five-Decade Institution in the State of Amazonas: Historical Trends, Scientific Contributions, and Research Priorities. | Rev Soc Bras Med Trop | 2026 | https://conductscience.org/library/papers/42484259 | PubMed |
| 42291620 | Investigation of Pharmacogenomic Variants in the CYP (P450) Family in Native American Populations of the Brazilian Amazon. | Int J Genomics | 2026 | https://conductscience.org/library/papers/42291620 | PubMed |
| 42037398 | Differential impact of Tafenoquine and Primaquine on Plasmodium vivax recurrence: the role of CYP2D6 variants. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42037398 | PubMed |
| 41894411 | Reduced cytochrome P-450 (CYP) 2D6 activity and Plasmodium vivax malaria risk in Amazonians: A retrospective, population-based cohort study. | PLoS Negl Trop Dis | 2026 | https://conductscience.org/library/papers/41894411 | PubMed |
| 41806469 | The evolving landscape of pharmacogenomics: Current achievements and future directions. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/41806469 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40316617
GET https://conductscience.org/api/papers/v1/40316617/references?page=2